CONNECT WITH US
Trial begins for Clarity Pharmaceuticals's #breastimaging radiotracer copper-64 SAR-Bombesin. The data emerging from this study will represent a great step forward to progress this product into other #diagnostic & #therapeutic trials in a range of cancers
Another milestone for the #Oncidiumfoundation: 200 registered hospitals.
Thank you to all the #nuclearmedicine experts that registered their treatment center using #Radiotheranostics for #cancercare.
Help patients worldwide by registering your center👇
The Sri Venkateswara Institute of Medical Sciences runs a department of #nuclearmedicine & provides high-end #radiotheranostics treatments. It strives to treat people in need thanks to donations made by visitors of the famous temple of this Indian city.